Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Minerva Pediatr ; 67(1): 19-24, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25602748

RESUMO

AIM: The aim of this study was to determine the prevalence of norovirus among children with acute gastroenteritis in 2009 and 2010. We also aimed that, to detecting the possible clinical and laboratory differences among cases in 2009 and 2010. METHODS: Fecal samples were collected from children under 16 years of age who were admitted for acute gastroenteritis. Norovirus was detected using immunochromatography. For the comparison of seasonal distribution, clinical manifestations, and laboratory results between cases, we divided subjects into two groups by year. RESULTS: Norovirus infection was detected in 112 of the 1027 collected samples (10.9%). In three cases with norovirus, other enteric viruses like rotavirus and adenovirus are detected concurrently, and these were excluded. After the exclusion of three cases with co-infections, statistical analysis was made in 109 cases. Most of the positive cases were between 1-24 months of age (N.=75, 67%). The rate of norovirus infection peaked in winter in 2010 (P<0.05). However, the rates were not significantly different between seasons in 2009 (P>0.05). We did not detect any positive cases in late summer and autumn in 2010. Diarrhea (97.2%), vomiting (95.4%), and abdominal pain (65.1%) were most frequently encountered symptoms of patients with norovirus. Leukocytosis and neutrophilia were significantly higher in 2010 than 2009 (P<0.05). CONCLUSION: The prevalence and clinical characteristics of norovirus in our study group is similar but seasonal distribution is different between two years. Most of the cases were <24 months of age. Like rotavirus, norovirus vaccine can be developed to prevent infection.


Assuntos
Infecções por Caliciviridae/epidemiologia , Gastroenterite/epidemiologia , Norovirus/isolamento & purificação , Dor Abdominal/epidemiologia , Dor Abdominal/virologia , Doença Aguda , Distribuição por Idade , Infecções por Caliciviridae/virologia , Criança , Pré-Escolar , Diarreia/epidemiologia , Diarreia/virologia , Gastroenterite/virologia , Hospitalização , Humanos , Lactente , Recém-Nascido , Prevalência , Estudos Retrospectivos , Estações do Ano , Vômito/epidemiologia , Vômito/virologia
2.
Aust Dent J ; 57(4): 435-9, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23186567

RESUMO

BACKGROUND: The aim of this pilot study was to evaluate the effects of mouthrinses containing 7.5% povidone iodine and 0.2% chlorhexidine on bacteraemia following impacted third molar surgery. METHODS: Thirty-four patients were enrolled in this study. Patients in the first group were asked to rinse their mouth with the mouthrinse containing 7.5% povidone iodine, patients in the second group were asked to rinse with the mouthrinse containing 0.2% chlorhexidine and patients in the third group were asked to rinse with 0.9% NaCl (sterile saline) solution. All rinses were used for one minute preoperatively. Peripheral venous blood samples were collected at baseline (preoperatively), 1 and 15 minutes after the completion of surgical tooth removal. Each blood sample was divided in two, placed in aerobic and anaerobic culture bottles and processed for microbiological examination. RESULTS: Bactaeremia was detected in 33% of the povidone iodine group, 33% of the chlorhexidine group and 50% of the control group. Isolated bacteria were 58% anaerobes and predominantly 92%Streptococcus species. Incidence of bacteraemia was reduced with chlorhexidine and povidone iodine mouthrinses in third molar surgery, although the difference was not statistically significant (p > 0.05). CONCLUSIONS: Bacteraemia was reduced with antibacterial mouthrinses in third molar surgery. The results of this study should be confirmed with further studies conducted on a larger patient population and with different antibacterial mouthrinses.


Assuntos
Antibacterianos/uso terapêutico , Bacteriemia/tratamento farmacológico , Clorexidina/uso terapêutico , Dente Serotino/cirurgia , Antissépticos Bucais/uso terapêutico , Povidona-Iodo/uso terapêutico , Dente Impactado/cirurgia , Idoso , Bacteriemia/diagnóstico , Bactérias Anaeróbias/efeitos dos fármacos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Antissépticos Bucais/química , Projetos Piloto , Cuidados Pré-Operatórios , Streptococcus/efeitos dos fármacos , Extração Dentária/efeitos adversos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...